AVBP
Price
$22.47
Change
+$0.50 (+2.28%)
Updated
Jan 14 closing price
Capitalization
929.24M
70 days until earnings call
Intraday BUY SELL Signals
CRVS
Price
$6.82
Change
+$0.32 (+4.92%)
Updated
Jan 14 closing price
Capitalization
509.33M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs CRVS

Header iconAVBP vs CRVS Comparison
Open Charts AVBP vs CRVSBanner chart's image
ArriVent BioPharma
Price$22.47
Change+$0.50 (+2.28%)
Volume$338.08K
Capitalization929.24M
Corvus Pharmaceuticals
Price$6.82
Change+$0.32 (+4.92%)
Volume$720.49K
Capitalization509.33M
AVBP vs CRVS Comparison Chart in %
AVBP
Daily Signal:
Gain/Loss:
CRVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVBP vs. CRVS commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and CRVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AVBP: $22.47 vs. CRVS: $6.82)
Brand notoriety: AVBP and CRVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 84% vs. CRVS: 53%
Market capitalization -- AVBP: $929.24M vs. CRVS: $509.33M
AVBP [@Biotechnology] is valued at $929.24M. CRVS’s [@Biotechnology] market capitalization is $509.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileCRVS’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • CRVS’s FA Score: 0 green, 5 red.
According to our system of comparison, AVBP is a better buy in the long-term than CRVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 6 TA indicator(s) are bullish while CRVS’s TA Score has 4 bullish TA indicator(s).

  • AVBP’s TA Score: 6 bullish, 4 bearish.
  • CRVS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than CRVS.

Price Growth

AVBP (@Biotechnology) experienced а +14.41% price change this week, while CRVS (@Biotechnology) price change was -3.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

AVBP is expected to report earnings on Mar 26, 2026.

CRVS is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVBP($929M) has a higher market cap than CRVS($509M). AVBP YTD gains are higher at: 11.680 vs. CRVS (-11.429). CRVS has higher annual earnings (EBITDA): -38.76M vs. AVBP (-162.42M). AVBP has more cash in the bank: 300M vs. CRVS (65.7M). AVBP has less debt than CRVS: AVBP (56K) vs CRVS (1.01M). AVBP (0) and CRVS (0) have equivalent revenues.
AVBPCRVSAVBP / CRVS
Capitalization929M509M183%
EBITDA-162.42M-38.76M419%
Gain YTD11.680-11.429-102%
P/E RatioN/AN/A-
Revenue00-
Total Cash300M65.7M457%
Total Debt56K1.01M6%
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVBPCRVS
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
83%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
CRVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCITX29.420.14
+0.48%
Victory Pioneer International Equ C
EMQIX10.330.04
+0.39%
Ashmore Emerging Markets Active Eq Instl
IVGIX20.690.06
+0.29%
VY® Invesco Growth and Income I
JCVVX20.000.02
+0.10%
JHancock Classic Value R5
FDETX28.47N/A
N/A
Fidelity Advisor Capital Development O

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+2.28%
CRNX - AVBP
49%
Loosely correlated
+2.04%
SYRE - AVBP
49%
Loosely correlated
+5.17%
DNLI - AVBP
49%
Loosely correlated
+0.88%
XNCR - AVBP
48%
Loosely correlated
+3.66%
ELVN - AVBP
48%
Loosely correlated
+1.17%
More

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with SYRE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
+4.92%
SYRE - CRVS
49%
Loosely correlated
+5.17%
KURA - CRVS
41%
Loosely correlated
+1.63%
RZLT - CRVS
41%
Loosely correlated
+9.68%
RGNX - CRVS
41%
Loosely correlated
-0.66%
AVBP - CRVS
40%
Loosely correlated
+2.28%
More